Objectives COVID-19 causes lung parenchymal and endothelial damage that lead to hypoxic acute respiratory failure (hARF). The influence of hARF severity on patients’ outcomes is still poorly ...

PaO2/FiO2（PF）比值被广泛用于评估重症患者的呼吸衰竭情况，以指导通气策略和预后判断。然而，由于该指标需要侵入性动脉 ...

为解决评估急性呼吸窘迫综合征（ARDS）严重程度时，仅依靠 Pa O 2 /FiO 2 存在局限性的问题，研究人员开展了 ARDS 分类的相关研究。结果表明仅用 Pa O 2 /FiO 2 分类存在不足，为未来研究指明方向，有重要意义。 在医疗领域，急性呼吸窘迫综合征（ARDS）一直是重症 ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The following is a summary of “Prognostic value of PaO2/FiO2 ratio in predicting clinical outcomes in COVID-19 patients,” published in the June 2024 issue of Critical Care by Canto-Costal et al.

The models use maximal deflection of esophageal pressure to quantify HFOT-related breathing effort (ΔPes) and the risk for strong breathing effort (ΔPes >10 cmH2O). Two models have been developed to ...

The PF ratio (PaO2/FiO2 ratio) is an essential indicator used in medicine to gauge the severity of a patient’s hypoxemic respiratory failure. This value helps healthcare professionals determine ...

The P/F ratio, also known as the PaO2/FiO2 ratio, is a valuable tool for evaluating oxygenation status in critically ill patients. It is commonly used to determine the severity of acute respiratory ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The performance of prognostic models for COVID-19 is ...

Although the PaO 2/FiO 2 derived from arterial blood gas analysis remains the gold standard for the diagnosis of acute respiratory failure, the SpO2/FiO2 has been investigated as a potential ...